BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21064019)

  • 1. [Modafinil in psychiatric disorders: the promising state reconsidered].
    Joos L; Docx L; Schmaal L; Sabbe BG; Dom G
    Tijdschr Psychiatr; 2010; 52(11):763-73. PubMed ID: 21064019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approved and investigational uses of modafinil : an evidence-based review.
    Kumar R
    Drugs; 2008; 68(13):1803-39. PubMed ID: 18729534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil in the treatment of excessive daytime sleepiness.
    Valentino RM; Foldvary-Schaefer N
    Cleve Clin J Med; 2007 Aug; 74(8):561-6, 568-71. PubMed ID: 17708127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.
    Myrick H; Malcolm R; Taylor B; LaRowe S
    Ann Clin Psychiatry; 2004; 16(2):101-9. PubMed ID: 15328903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
    Becker PM; Schwartz JR; Feldman NT; Hughes RJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of modafinil: Potential clinical uses and mechanisms of action.
    Ballon JS; Feifel D
    J Clin Psychiatry; 2006 Apr; 67(4):554-66. PubMed ID: 16669720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.
    Schwartz JR; Feldman NT; Fry JM; Harsh J
    Sleep Med; 2003 Jan; 4(1):43-9. PubMed ID: 14592359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modafinil (Midiodal): wakefulness stimulant in narcoleptic patients].
    Arnulf I; Derenne JP
    Presse Med; 2000 Jun; 29(20):1131-2. PubMed ID: 10901794
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sleep and wakefulness drugs and their indications].
    Bourin M
    Ann Pharm Fr; 2007 Jul; 65(4):251-7. PubMed ID: 17652993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study.
    Joo EY; Tae WS; Jung KY; Hong SB
    J Sleep Res; 2008 Mar; 17(1):82-8. PubMed ID: 18275558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.
    Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R
    Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modafinil: pharmacology and therapeutic perspectives].
    Billiard M
    Rev Neurol (Paris); 2003 Jan; 159(1):122-5. PubMed ID: 12618664
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis.
    Wang SM; Han C; Lee SJ; Jun TY; Patkar AA; Masand PS; Pae CU
    J Psychiatr Res; 2017 Jan; 84():292-300. PubMed ID: 27810669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.